IVA.PA Overview

Company Profile

Related stocks

MEDCL.PA • France

MEDINCELL S.A.

29.06 EUR

1.17B USD 1Y -11.3%

VLA.PA • France

VALNEVA SE

2.53 EUR

538.3M USD 1Y -47.4%

NANO.PA • France

NANOBIOTIX

21.24 EUR

1.21B USD 1Y -7.6%

OXB.L • United Kingdom

OXFORD BIOMEDICA PLC ORD 50P

521 GBp

834.6M USD 1Y -20.8%

MLTX • Switzerland

MoonLake Immunotherapeutics

10.82 USD

920.85M USD 1Y +16.3%

SLNCF • United Kingdom

Silence Therapeutics, Plc.

4 USD

745.85M USD 1Y +150%

QURE • Netherlands

uniQure N.V.

22.59 USD

1.57B USD 1Y -62.4%

GUBRA.CO • Denmark

Gubra A/S

283 DKK

696.37M USD 1Y -38%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

65.9% p.a.

Max Drawdown (5Y)

-88.8%

Sharpe Ratio (5Y)

-0.40

Beta Factor

1.00

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 235%.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (65.9% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -90.7% in the extended horizon.